Diagnostic Catheterization and Coronary Therapeutics

Improving Treatment to Improve Lives

The Minneapolis Heart Institute Foundation® (MHIF) has built its reputation as one of the nation’s most respected and distinguished leaders in coronary artery disease research and treatment. This national recognition in coronary therapeutics comes, in part, from MHIF’s pioneering work in the treatment of heart attacks. In 2003, MHIF investigators along with Minneapolis Heart Institute® at Abbott Northwestern Hospital developed a program, called Level One, which focuses on rapid transfer and treatment of heart attack patients who present to hospitals without advanced cardiovascular capabilities. The Level One Program has proven that rural patients, when appropriately treated, can expect the same level of care and outcomes as those who present to major medical centers. It has become the model for care of heart attack victims across the nation.

Other research highlights include helping to develop drug-eluting stents that have revolutionized coronary care, and perfecting new products and techniques for chronic total occlusions, completely blocked arteries that previously could not be treated without bypass surgery. The Minneapolis Heart Institute Foundation continues to evaluate new treatment delivery models such as Tele-Health, which provides cardiology consultation from Minneapolis Heart Institute® physicians for rural clinics. Research from MHIF is a critical component to best in class treatment, and a key contributor to advancing the treatment of coronary artery disease worldwide.

Current Studies